< Back to companies

Adherium (ASX.ADR) is a global leader in digital health technologies that address sub-optimal medication use in chronic disease. Its Hailie™ platform has been independently proven to improve medication adherence and health outcomes for patients with chronic respiratory disease. Adherium has the broadest range of "smart"​ devices for respiratory medications globally. Adherium's Hailie™ sensors attach to prescription inhalers to provide reminders and monitoring of inhaler usage.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2015
Website
www.adherium.com/

Categories

Digital Health ServicesMedication Management

Disease Areas

Technologies

Digital Health TechnologiesMedication Adherence Technology
Only accessible to MedStartr community members. Join now

What do you think of Adherium?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now